Cell cycle dysregulation in pituitary oncogenesis.

Cell cycle dysregulation in pituitary oncogenesis.

The cell cycle is the process by which cells grow, replicate their genome and divide. The cell cycle control system is a cyclically-operating biochemical device constructed from a set of interacting proteins that induce and coordinate proper progression through the cycle, and includes cyclins, cycli...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Muşat, M, Vax, V, Borboli, N, Gueorguiev, M, Bonner, S, Korbonits, M, Grossman, AB
Natura:	Journal article
Lingua:	English
Pubblicazione:	2004

Documenti analoghi

Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.
di: Gueorguiev, M, et al.
Pubblicazione: (2009)

The Kruppel-like transcription factor 6 gene in sporadic pituitary tumours.
di: Vax, V, et al.
Pubblicazione: (2003)

Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
di: Vax, V, et al.
Pubblicazione: (2003)

Enhanced protein kinase B/Akt signalling in pituitary tumours.
di: Musat, M, et al.
Pubblicazione: (2005)

Akting and cycling: a tale of the pituitary.
di: Grossman, AB, et al.
Pubblicazione: (2004)

Cyclins and their related proteins in pituitary tumourigenesis.
di: Muşat, M, et al.
Pubblicazione: (2010)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
di: Kaltsas, G, et al.
Pubblicazione: (2002)

Cell cycle dysregulation in breast cancer - the roles of Jab1 and Archipelago.
di: Bonner, SE, et al.
Pubblicazione: (2004)

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
di: Morris, D, et al.
Pubblicazione: (2003)

Pituitary tumors in 2010: a new therapeutic era for pituitary tumors.
di: Gueorguiev, M, et al.
Pubblicazione: (2011)

Dysregulated metabolism contributes to oncogenesis
di: Hirschey, Matthew D., et al.
Pubblicazione: (2016)

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
di: Morris, D, et al.
Pubblicazione: (2005)

The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors.
di: Musat, M, et al.
Pubblicazione: (2002)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
di: Korbonits, M, et al.
Pubblicazione: (2001)

Presence of ghrelin in normal and adenomatous human pituitary.
di: Korbonits, M, et al.
Pubblicazione: (2001)

A mutation and expression analysis of the oncogene BRAF in pituitary adenomas.
di: Ewing, I, et al.
Pubblicazione: (2007)

Role of microRNA in oncogenesis of pituitary tumors and their practical significance
di: A M Lapshina, et al.
Pubblicazione: (2016-08-01)

PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
di: Emery, M, et al.
Pubblicazione: (2006)

Where metabolism meets oncogenesis: another false lead?
di: Grossman, AB
Pubblicazione: (2010)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
di: Korbonits, M, et al.
Pubblicazione: (1999)

Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
di: Pyle, M, et al.
Pubblicazione: (2003)

Role of regulatory factors in pituitary tumour formation.
di: Korbonits, M, et al.
Pubblicazione: (2004)

Cyclin D and cyclin E expression in normal and adenomatous pituitary.
di: Jordan, S, et al.
Pubblicazione: (2000)

Novel molecular aspects of pituitary adenomas.
di: Hubina, E, et al.
Pubblicazione: (2005)

The pathology of pituitary adenomas from a clinical perspective.
di: Dworakowska, D, et al.
Pubblicazione: (2011)

The release of leptin and its effect on hormone release from human pituitary adenomas.
di: Korbonits, M, et al.
Pubblicazione: (2001)

Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors.
di: Korbonits, M, et al.
Pubblicazione: (2001)

Ghrelin--a hormone with multiple functions.
di: Korbonits, M, et al.
Pubblicazione: (2004)

Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
di: Preda, V, et al.
Pubblicazione: (2014)

Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
di: Isidori, A, et al.
Pubblicazione: (2002)

Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis.
di: Couvé, S, et al.
Pubblicazione: (2014)

Protein western array analysis in human pituitary tumours: insights and limitations.
di: Ribeiro-Oliveira, A, et al.
Pubblicazione: (2008)

Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
di: Lidhar, K, et al.
Pubblicazione: (1999)

Pituitary radiotherapy.
di: Molitch, M, et al.
Pubblicazione: (2009)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
di: Korbonits, M, et al.
Pubblicazione: (1995)

STOP AKTING TO TREAT ENDOCRINE TUMOURS
di: Musat, M, et al.
Pubblicazione: (2009)

Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
di: Dworakowska, D, et al.
Pubblicazione: (2009)

Epigenetic dysregulation in pituitary tumors
di: Shariq, O, et al.
Pubblicazione: (2019)

Mutational analysis of ghrelin and the growth hormone secretagogue receptor
di: Gueorguiev, M, et al.
Pubblicazione: (2004)

Expression of menin gene mRNA in pituitary tumours.
di: Satta, M, et al.
Pubblicazione: (1999)